DG-GT Hybrid Symposium Making Gene Therapy a Clinical Reality
Herrenhausen Palace, Hannover, 23-25 March 2022
Held in collaboration with the Volkswagen Foundation
DG-GT's Making Gene Therapy a Clinical Reality Symposium took place from 23-25 March 2022 at Herrenhausen Palace, Hannover.
132 delegates attended the event in-person, and 47 attended virtually.
The symposium began with an Education Session for PhD Students, MD Students and MD PhD Students. View Education Session Programme.
Meeting Organisers
Local Organising Committee
- Frank Bengel, Hannover Medical School
- Hildegard Büning, Hannover Medical School
- Tobias Cantz, Hannover Medical School
- Christine Falk, Hannover Medical School
- Boris Fehse, University of Hamburg
- Melanie Galla, Hannover Medical School
- Ulrike Köhl, Fraunhôfer Institute, Leipzig
- Thomas Moritz, Hannover Medical School
- Michael Ott, Hannover Medical School
- Martin Sauer, Hannover Medical School
- Axel Schambach, Hannover Medical School
- Brigitte Schlegelberger, Hannover Medical School
- Thomas Thum, Hannover Medical School
Meeting Partner - Volkswagen Foundation
- Mareike Rüßmann, Volkswagen Foundation
Award Winners
Congratulations to the oral and poster presentation award winners, who presented at the DG-GT Hybrid Symposium in Hannover, 23-25 March 2022.
Oral Presentation Winners
Lea Krutzke, University of Ulm Process-related impurities in the ChAdOx1 nCov-19 vaccine
Viviane Dettmer-Monaco, Medical Center- University of Freiburg Gene editing of hematopoietic stem cells restores the cytotoxic T cell response in a murine model of familial hemophagocytic lymphohistiocytosis type 3
Adrian Schwarzer, Hannover Medical School A four-color AAV6 system for efficient biallelic homology-directed genome editing (HDR) without AAV vector integration into CRISPR-Cas9 induced double-strand breaks
Lea-Isabell Schwarze, University Medical Center Hamburg-Eppendorf CCR5-edited CAR T cells for the treatment of HIV-positive cancer patients
Poster Presentation Winners
Rajendra Khanal, Hannover Medical School MicroRNAs regulate SARS-CoV-2 infection in primary human hepatocytes by modulating the entry factors ACE2 and TMPRSS2
Tobias Bexte, Hospital of the Goethe University Frankfurt; Frankfurt Cancer Institute, Goethe University Frankfurt am Main; University Cancer Center (UCT) Frankfurt CRISPR-Cas9 based gene editing of the immune checkpoint NKG2A enhances NK cell mediated cytotoxicity against multiple myeloma
Alice Rovai, Medizinische Hochschule Hannover (MHH) In vivo adenine base editing reverts C282Y and improves iron metabolism in hemochromatosis mice
Ala Dibas, University Medical Centre, Freiburg In vitro modeling of CAR T cell induced cytokine release syndrome validates two genetic targets to mitigate the condition
With thanks to our sponsors and partners
